📋 Tender Overview
The National Institute of Health INS of the Ministry of Health Minsa has certified 100 laboratories to process molecular tests that detect COVID-19. In this way the 25 regions of our country already have the infrastructure and capacity to carry out this type of diagnosis. The INS specified that of the 100 laboratories authorized so far 6 belong to universities 45 are private and 49 public. In this last group the distribution is as follows 5 are administered by the INS 1 located in Lima Loreto and 3 Covid Maskaq mobile laboratories and 25 reference laboratories are located in each of the regions of our country. Likewise 9 are in Minsa hospitals located in Lambayeque Lima Madre de Dios Ica La Libertad 1 laboratory administered by the Armed Forces and 9 laboratories under the direction of EsSalud in Cusco Arequipa Lima Junn Piura Lambayeque and Loreto. Specialized molecular biology laboratories are necessary to identify the virus and study its characteristics contributing to the control of the pandemic. This requires technology equipment and trained personnel. It should be noted that the National Center for Public Health CNSP of the INS is the body in charge of regulating developing evaluating and disseminating research and appropriate technologies for the prevention and control of diseases as well as providing training for obtaining conservation and shipment of samples of the SARS-CoV-2 virus. It is also responsible for making the technology transfer to public health laboratories and Public Health Service Providers Ipress of the Reverse Transcription - Loop-Mediated Isothermal Amplification RT-LAMP method. The laboratory that wishes to carry out the molecular diagnosis for COVID-19 must be an Ipress and comply with the requirements established in Directive No. 054-INS CNSP-V.02. Once the request is received a team of INS professionals verifies and verifies the infrastructure conditions personal biosafety and quality of the molecular biology laboratory.
